CD4+CD25-Nrp1+ T Cells Synergize with Rapamycin to Prevent Murine Cardiac Allorejection in Immunocompetent Recipients

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Yuan, Qing ^a   Hong, Shanjuan ^b   Shi, Bingyi ^a   Kers, Jesper ^c   Li, Zhouli ^a   Pei, Xiangke ^d   Xu, Liang ^a   Wei, Xing ^a   Cai, Ming ^a  

^a 309TH HOSPITAL OF PLA   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d The 281th Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; NEUROPILIN 1; RAPAMYCIN; RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ CD252- NRP1+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; EFFECTOR CELL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFER; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSLATIONAL RESEARCH;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOCOMPETENCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; NEUROPILIN-1; SIROLIMUS; T-LYMPHOCYTES, REGULATORY;

MURINAE;

EID: 84875922237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061151     Document Type: Article

References (37)

1. Lechler RI, Sykes M, Thomson AW, Turka LA, (2005) Organ transplantation-how much of the promise has been realized? Nat Med 11: 605-613.
2. Wood KJ, Sakaguchi S, (2003) Regulatory T cells in transplantation tolerance. Nature reviews Immunology 3: 199-210.
3. Morelli AE, Thomson AW, (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nature reviews Immunology 7: 610-621.
4. Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, et al. (2008) Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 14: 88-92.
5. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, et al. (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. Journal of Immunology 166: 3789-3796.
6. Xia G, He J, Leventhal JR, (2008) Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 8: 298-306.
7. Ma A, Qi S, Wang Z, Massicotte E, Dupuis M, et al. (2009) Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice. Int Immunopharmacol 9: 553-563.
8. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S, (1996) Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 62: 1200-1206.
9. Hall BM, Pearce NW, Gurley KE, Dorsch SE, (1990) Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 171: 141-157.
10. Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L, (2000) Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 6: 782-789.
11. Staton CA, Kumar I, Reed MW, Brown NJ, (2007) Neuropilins in physiological and pathological angiogenesis. J Pathol 212: 237-248.
12. Roskoski R Jr, (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critical reviews in oncology/hematology 62: 179-213.
13. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, et al. (2004) Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 34: 623-630.
14. Ming C, Chang L, Hongming Z, Xiangke P, Bingyi S, et al. (2009) Effect of Nrp1+T cells on the regulation of lymphocyte proliferation and survival time of allograft. Med J Chin PLA 34: 1276-1280.
15. Xiangke P, Ming C, Hongming Z, Chang L, Lijun X, et al. (2008) Comparsion between Neuropilin-1+T cells CD4+CD25+ regulatory T cells. Chin J Cell Mol Immunol 24: 3.
16. Solomon BD, Mueller C, Chae WJ, Alabanza LM, Bynoe MS, (2011) Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 108: 2040-2045.
17. Wood KJ, (2011) Regulatory T cells in transplantation. Transplant Proc 43: 2135-2136.
18. Fan H, Cao P, Game DS, Dazzi F, Liu Z, et al. (2011) Regulatory T cell therapy for the induction of clinical organ transplantation tolerance. Semin Immunol 23: 453-461.
19. Ezzelarab M, Thomson AW, (2011) Tolerogenic dendritic cells and their role in transplantation. Semin Immunol 23: 252-263.
20. Li L, Boussiotis VA, (2011) Molecular and functional heterogeneity of T regulatory cells. Clinical immunology 141: 244-252.
21. Kapp JA, Ke Y, (1997) The role of gammadelta TCR-bearing T cells in oral tolerance. Research in immunology 148: 561-567.
22. Zhang ZX, Lian D, Huang X, Wang S, Sun H, et al. (2011) Adoptive transfer of DNT cells induces long-term cardiac allograft survival and augments recipient CD4(+)Foxp3(+) Treg cell accumulation. Transpl Immunol 24: 119-126.
23. Tordjman R, Lepelletier Y, Lemarchandel V, Cambot M, Gaulard P, et al. (2002) A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol 3: 477-482.
24. Catalano A, Caprari P, Moretti S, Faronato M, Tamagnone L, et al. (2006) Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 107: 3321-3329.
25. Lepelletier Y, Moura IC, Hadj-Slimane R, Renand A, Fiorentino S, et al. (2006) Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur J Immunol 36: 1782-1793.
26. Milpied P, Renand A, Bruneau J, Mendes-da-Cruz DA, Jacquelin S, et al. (2009) Neuropilin-1 is not a marker of human Foxp3+ Treg. Eur J Immunol 39: 1466-1471.
27. Battaglia A, Buzzonetti A, Monego G, Peri L, Ferrandina G, et al. (2008) Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Immunology 123: 129-138.
28. Weiss JM, Bilate AM, Gobert M, Ding Y, Curotto de Lafaille MA, et al. (2012) Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med 209: 1723-1742.
29. Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, et al. (2012) Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 209: 1713-1722.
30. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG, (2008) Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28: 402-413.
31. Glinka Y, Prud'homme GJ, (2008) Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 84: 302-310.
32. Min SI, Ha J, Park CG, Won JK, Park YJ, et al. (2009) Sequential evolution of IL-17 responses in the early period of allograft rejection. Experimental & molecular medicine 41: 707-716.
33. Regateiro FS, Howie D, Cobbold SP, Waldmann H, (2011) TGF-beta in transplantation tolerance. Curr Opin Immunol 23: 660-669.
34. Raimondi G, Sumpter TL, Matta BM, Pillai M, Corbitt N, et al. (2010) Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. Journal of Immunology 184: 624-636.
35. Zhang C, Shan J, Lu J, Huang Y, Feng L, et al. (2010) Rapamycin in combination with donor-specific CD4+CD25+Treg cells amplified in vitro might be realize the immune tolerance in clinical organ transplantation. Cell Immunol 264: 111-113.
36. Bae D, Lu S, Taglienti CA, Mercurio AM, (2008) Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2. J Biol Chem 283: 28074-28080.
37. Manns RP, Cook GM, Holt CE, Keynes RJ, (2012) Differing semaphorin 3A concentrations trigger distinct signaling mechanisms in growth cone collapse. J Neurosci 32: 8554-8559.